Enteric ChAT-expressing neurons as new target for Lactobacillus plantarum ameliorates inflammatory bowel diseases
Bing XiaiD, Yuwei SuniD, Jialin Wang, Yike LiuiD, Lu WangiD, Shiqi Jiang, Gaiyan Bai, Ruijing ZhangiD, Yu ZhangiD, Rong-Wei KouiD, Danna WangiD, Beita ZhaoiD, Junjie YiiD, Yu Vincent FuiD, Xiaoning LiuiD, Xuebo LiuiD
Abstract
The gut microbiota plays a crucial role in inflammatory bowel diseases (IBD), yet how specific microbial components influence disease progression remains incompletely understood. Our study reveals that decreased abundance of Lactobacillus species correlates with ulcerative colitis severity in patients. Among tested strains, L. plantarum A736, isolated from traditional fermented foods, demonstrated remarkable efficacy in ameliorating dextran sulfate sodium (DSS)-induced colitis in a mouse model. Strikingly, multi-omics analysis revealed that L. plantarum A736 uniquely enhances choline acetyltransferase-expressing (ChAT+) neurons in the enteric nervous system and elevates acetylcholine (ACh) levels. Further analysis identified that L. plantarum A736 metabolizes tryptophan to produce indole-3-lactic acid (ILA), and supplementation with ILA significantly mimics this strains anti-inflammatory effects by activating ChAT+ neurons. Crucially, selective ablation of colonic ChAT+ neurons completely abolished the therapeutic benefits of both L. plantarum A736 and ILA, establishing their essential role in mediating these effects. These findings demonstrate for the first time that microbial metabolites can directly modulate enteric neuronal circuits to regulate gut immunity. The identified ILA-ChAT+ neuron axis represents a novel neuro-immune pathway that could be targeted for IBD treatment. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/673902v1_ufig1.gif" ALT="Figure 1"> View larger version (63K): org.highwire.dtl.DTLVardef@1e0d3c5org.highwire.dtl.DTLVardef@16f5481org.highwire.dtl.DTLVardef@152283org.highwire.dtl.DTLVardef@18cfad0_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Secondary bile acid lithocholic acid ameliorates colitis-like inflammation in a human intestine-on-chip system
Tim Kaden, Manuel Allwang, … Alexander Sandy Mosig·Frontiers in ImmunologyPeer-reviewed·May 8, 2026
- The gut lactic acid bacteria metabolite, 10-oxo-cis-6,trans-11-octadecadienoic acid, suppresses inflammatory bowel disease in mice by modulating the NRF2 pathway and GPCR-signaling
M. Ando, K. Nagata, … C. Nishiyama·bioRxiv·Feb 22, 2023
- The Secreted Metabolite Isopentenyladenine from Faecalibacterium prausnitzii Mitigates Gut Inflammation
Lina Yao, Angelo Solania, … Dennis W. Wolan·bioRxiv·Aug 24, 2025
- Red cabbage juice-mediated gut microbiota modulation improves intestinal epithelial homeostasis and ameliorates colitis
Emily Jean Wilson, Nagabhishek Sirpu Natesh, … Satyanarayana Rachagani·International Journal of Molecular SciencesPeer-reviewed·Dec 30, 2023
- Diet prevents the expansion of segmented filamentous bacteria and ileo-colonic inflammation in a model of Crohn's disease
A. Metwaly, J. Jovic, … D. Haller·bioRxiv·Jul 6, 2022
- Multi-component functionalized Bifidobacterium longum hydrogel for multi-target integrated therapy of colitis-associated anxiety and depression
S T Zhang, Yu Zhang, … Feng Zhu·Advanced SciencePeer-reviewed·Jun 22, 2026